Alpha-fetoprotein (AFP) is an oncofetal glycoprotein that has been used as a tumor marker
for hepatocellular carcinoma (HCC) in combination with ultrasound and other imaging …

An early diagnosis of hepatocellular carcinoma (HCC) followed by effective treatment is
currently critical for improving the prognosis and reducing the associated economic burden …

Over the past decade, immune checkpoint blockade (ICB) therapy has revolutionized the
outlook for oncology with significant and sustained improvement in the overall patient …

Background Tumor proliferation is frequently accompanied by aberrant enzyme production.
We aim to investigate the potential predictive value of both plasma alkaline phosphatase …

Background Aberrant DNA methylation may offer opportunities in revolutionizing cancer
screening and diagnosis. We sought to identify a non-invasive DNA methylation-based …

Cancer remains a global health challenge, with high morbidity and mortality, despite the
recent advances in diagnosis and treatment. Multiple compounds assessed as novel …

Hepatocellular carcinoma (HCC) is a common cancer in the world, and its incidence is
increasing yearly. Hepatitis B virus (HBV) infection and hepatitis C virus (HCV) infection are …

Noncoding RNAs have been verified to regulate the infiltration of macrophages to accelerate
tumor biological progression, however the regulation of macrophages by circular RNAs in …

Early hepatocellular carcinoma (HCC) diagnosis is challenging. Moreover, for patients with
alpha-fetoprotein (AFP)-negative HCC, this challenge is augmented. MicroRNAs (miRs) …

Hepatocellular carcinoma (HCC) is a common cause of cancer-related deaths worldwide.
Despite advances in systemic therapies, patient survival remains low due to late diagnosis …